文献速递炎症性肠病

血清富亮氨酸α2糖蛋白:克罗恩病透壁炎症的新型生物标志物

Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease.
PubMed 文献 · Am J Gastroenterol · 2022-12-23

本研究对2020年6月至2021年8月连续纳入的227例克罗恩病患者行磁共振小肠造影(MRE),前瞻性比较MRE表现与包括富亮氨酸α2糖蛋白(LRG)在内的临床及实验室数据。LRG与MRE评分呈正相关,对透壁炎症的曲线下面积高于CDAI和C反应蛋白,高LRG水平与住院、手术及临床复发相关。

要点

  • LRG与sMaRIA评分(r=0.576)及5点分类评分(r=0.633)均呈正相关,P<0.01。
  • LRG≥14 μg/mL对sMaRIA评分≥4的敏感性67%、特异性90%,对5点评分≥9的敏感性73%、特异性89%。
  • 高LRG水平患者与克罗恩病相关住院、手术及临床复发强相关,P均<0.01。

核心结论

  • LRG是检测克罗恩病患者透壁活动性的高准确度血清生物标志物,结果需在进一步多中心研究中验证。

研究设计与样本

  • 前瞻性研究,2020年6月至2021年8月连续纳入227例克罗恩病患者,行磁共振小肠造影(MRE),并与包括LRG在内的临床和实验室数据比较。
  • MRE采用2种经过验证的评分系统评估,透壁炎症分别定义为最大简化磁共振活动指数(sMaRIA)评分≥4和5点分类评分≥9。

主要发现

  • LRG与MRE总评分呈正相关:sMaRIA评分r=0.576,P<0.01;5点评分r=0.633,P<0.01。
  • 随着MRE评分升高,LRG血清浓度显著升高(P<0.01)。
  • LRG对sMaRIA评分≥4和5点评分≥9的曲线下面积分别为0.845和0.869,均显著高于CDAI(P<0.01)和C反应蛋白(P<0.01)。
  • LRG≥14 μg/mL对sMaRIA评分≥4的敏感性为67%、特异性为90%,对5点评分≥9的敏感性为73%、特异性为89%。
  • 与低LRG水平患者相比,高LRG水平患者与克罗恩病相关住院、手术和临床复发强相关(P均<0.01)。

关键数值与推荐

  • 透壁炎症定义为最大sMaRIA评分≥4和5点分类评分≥9。
  • LRG对sMaRIA评分≥4的曲线下面积为0.845,对5点评分≥9的曲线下面积为0.869。
  • LRG≥14 μg/mL对sMaRIA评分≥4的敏感性67%、特异性90%,对5点评分≥9的敏感性73%、特异性89%。

临床怎么用

  • 作者认为LRG是检测克罗恩病患者透壁活动性的高准确度血清生物标志物,结果需在进一步多中心研究中验证。

局限性

  • 原文指出结果需在进一步多中心研究中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Leucine-rich alpha-2 glycoprotein (LRG) is a newly studied biomarker for inflammatory diseases. This study aimed to investigate whether LRG can be used for evaluating transmural activity in patients with Crohn's disease (CD). METHODS: We performed magnetic resonance enterography (MRE) in 227 consecutive patients with CD from June 2020 to August 2021. We prospectively compared MRE findings with clinical and laboratory data including LRG. MRE was evaluated using 2 validated scoring systems, and transmural inflammation was defined as having a maximum simplified magnetic resonance index of activity (sMaRIA) score of ≥4 and a 5-point classification score of ≥9, respectively. RESULTS: The correlation between LRG and the total MRE score showed a positive correlation ( r = 0.576 for the sMaRIA score, P < 0.01, and r = 0.633 for the 5-point score, P < 0.01). Serum concentrations of LRG significantly increased as MRE scores increased ( P < 0.01). The area under the curve of LRG for a sMaRIA score of ≥4 and a 5-point score of ≥9 was 0.845 and 0.869, respectively, which was significantly higher than that of CDAI ( P < 0.01) or C-reactive protein ( P < 0.01). LRG levels of ≥14 μg/mL had a 67% sensitivity and 90% specificity for a sMaRIA score of ≥4 and a 73% sensitivity and 89% specificity for a 5-point score of ≥9. Patients with high LRG levels were also strongly associated with CD-related hospitalization, surgery, and clinical relapse compared with those with low LRG levels ( P < 0.01 for all). DISCUSSION: LRG is a highly accurate serum biomarker for detecting transmural activity in patients with CD. Results need to be validated in further multicenter studies.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Takenaka K, Kitazume Y, Kawamoto A, et al. Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease. Am J Gastroenterol. 2022. PMID: 36571769. doi:10.14309/ajg.0000000000002127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。